2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH ANDREA APOLO
Immune Checkpoint Inhibitors Trials in Urothelial Cancer: Recent Updates and Future Outlook

VIEW ALL BLADDER CANCER VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH TOM KEANE
A Look at Established Paradigms in Androgen Deprivation Therapy in the Treatment of Advanced Prostate Cancer

VIEW ALL ADV PROSTATE VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH JEREMIE CALAIS
Molecular Imaging for Prostate Cancer Salvage Radiotherapy Planning

VIEW ALL IMAGING VIDEOS

2019 ASCO GU Symposium

2019 ASCO GU Symposium

INTERVIEW WITH FRED SAAD
Delaying Disease Progression in Early Nonmetastatic CRPC Treatment

VIEW ALL nmCRPC VIDEOS

Featured Videos

#WCE2014 - Single versus dual-console robot-assisted radical prostatectomy: 
Impact on intraoperative and postoperative outcomes in a teaching institution - Session Highlights

TAIPEI, TAIWAN (UroToday.com) - Many resident training programs have adopted a dual console Intuitive Da Vinci Robotic Surgical system in hopes of aiding robotic surgical training. This allows two surgeons to control the robotic arms at the same time, in parallel, or quickly alternating between the surgeons.

wceDr. Aaron Lay presented new data with regard to outcomes after introducing the robot. They looked at whether the introduction of the dual console helps with patient outcomes or has any real benefit in a residency training program.

They reviewed 381 cases of robotic prostatectomy (RALP) by a single surgeon between 2006-2012, comparing those patients who had their RALP before and after introduction of the Dual Console at the University of Texas, Southwestern. Each surgery was performed with the chief resident or fellow assisting and at the console.

Interestingly, after introducing the dual console, mean operative time was reduced from 222 minutes to 171 minutes. Fewer intraoperative and postoperative complications were seen, and there were no differences in functional (continence, erectile function) or oncologic outcomes.

Presented by Aaron Lay, Monica S.C. Morgan,
 Nabeel A. Shakir, Maurilio Garcia-Gill, Jeffrey C. Gahan, Justin I. Friedlander, Claus G. Roehrborn, and Jeffrey A. Cadeddu at the 32nd World Congress of Endourology & SWL - September 3 - 7, 2014 - Taipei, Taiwan

University of Texas Southwestern, Department of Urology, USA

Written by Adam Kaplan, MD, chief resident, Department of Urology, School of Medicine, University of California-Irvine, and medical writer for UroToday.com

 

Conference Coverage
 
Recent data from conferences worldwide
Journals
Publications focusing on urologic cancer treatments through original manuscripts
Everyday Urology Volume 4 Issue 1

Everyday Urology™ - Oncology Insights

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe